BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30

• BioCapital

  Panacea Pharmaceuticals, Inc. Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies

  September 3, 2008

   · 

  6 min read
• BioCapital

  Rexahn Pharmaceuticals, Inc. Expands Cancer Patent Portfolio

  September 3, 2008

   · 

  1 min read
• Business

  Stentys Appoints René Spaargaren, MD, as Chief Medical Officer

  September 3, 2008

   · 

  1 min read
• Business

  Azaya Therapeutics, Inc. Licenses Promising Treatment for Head and Neck Cancers

  September 3, 2008

   · 

  1 min read
• Pharm Country

  Bristol-Myers Squibb Company and AstraZeneca PLC to Hold Investor Teleconference to Discuss EASD Highlights

  September 3, 2008

   · 

  1 min read
• Deals

  GeneThera, Inc. Rules Out Oxford BioMedica PLC Offer

  September 3, 2008

   · 

  1 min read
• Drug Development

  Aeris Therapeutics, Inc. Announces Phase 2 Trial Results for Non-Surgical Emphysema Treatment

  September 3, 2008

   · 

  1 min read
• Drug Development

  OSI Pharmaceuticals, Inc. Initiates Clinical Development Program for Anti-Diabetes Candidate, PSN821

  September 3, 2008

   · 

  1 min read
• Pharm Country

  Celgene Corporation to Present at the Thomas Weisel Partners Experts in Growth Healthcare Conference 2008

  September 3, 2008

   · 

  1 min read
• Business

  Ipsogen Consolidates its Position in North America and Appoints Susan Hertzberg President

  September 3, 2008

   · 

  2 min read